secwatch.observer — SEC 8-K summary
======================================

Issuer:     CASTLE BIOSCIENCES INC (CSTL)
CIK:        0001447362
Form:       8-K
Filed at:   2022-01-05T23:59:59+00:00
Accession:  0001447362-22-000005
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Castle Biosciences Chief Business Officer resigns; enters consulting agreement with vesting extension
--------------------------------------------------------------------------------

- Bernhard Spiess resigns as CBO effective Dec 31, 2021; separation agreement signed Dec 29, 2021.
- Receives accrued salary ($16,666.67), PTO payout ($72,783.74), and 2021 bonus (50% salary × board-approved corp attainment).
- Consulting agreement at $250/hour through Dec 31, 2022; outstanding equity continues vesting during consulting term.
- Non-competition for 1 year and non-solicitation for 3 years after consulting ends.
- Company may terminate consulting agreement immediately for any reason.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1447362/000144736222000005/0001447362-22-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1447362/000144736222000005/cstl-20211229.htm
  HTML page:      https://secwatch.observer/filing/0001447362-22-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer